Serum C4 levels can be used as a screening test because quantitative or qualitative C1-INH deficiency leads to permanent complement system activation, which is accompanied by C4 consumption, even when patients are not experiencing an angioedema attack. This evidence concerns the gene C4A and hyperinsulinemic hypoglycemia, familial, 4.